A plain-language guide

Duchenne muscular dystrophy

What's known, what's still uncertain, and what's actively debated, written plainly, and built only from published medical research.

Established map · 36 sourced statements Every statement names its source Updated 2026-08-04
Please read this first. This guide is a companion to your medical team, not a replacement, and it is not medical advice. Everything here is tied to published research. If something you expected is not here, it almost always means we have not mapped a source for it yet, not that it is unknown to medicine. Duchenne muscular dystrophy is an early, growing map, so it will look incomplete on purpose: we would rather show less and have every line be something you can check than fill the page with claims we cannot stand behind. For anything about your own situation, your clinicians hold the full picture. How this guide is built and why.

What's Duchenne muscular dystrophy?

Duchenne muscular dystrophy is a severe inherited muscle disease caused by mutations in the dystrophin (DMD) gene. Without working dystrophin, muscle is gradually damaged and replaced, causing progressive weakness from early childhood.

Also indexed asOMIM:310200, MONDO:0010679
Features mapped22
Treatments mapped3
Published sources18
Last reviewed2026-08-04

Signs and symptoms

Flexion contracture

People with duchenne muscular dystrophy may develop joint contractures, where a joint becomes tight and stiff and cannot fully straighten or bend.

Limited evidenceSource: PMID:30275252
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesOMIM:310200
Notesplain_language confirmed from PMID:30275252 via curation 2026-06-24 [claude-draft]. | regrounded primary OMIM:310200 -> PMID:30275252 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26

Calf muscle pseudohypertrophy

Enlarged-looking calves (calf pseudohypertrophy) are characteristic; the muscle is being replaced by fat and fibrous tissue rather than being strong.

Limited evidenceSource: PMID:37970286
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:41439068, OMIM:310200
Notesplain_language confirmed from PMID:41439068 via curation 2026-06-12. | regrounded primary OMIM:310200 -> PMID:37970286 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26

Calf muscle hypertrophy

The calf muscles often look enlarged (calf pseudohypertrophy). This is because muscle is gradually replaced by fat and scar tissue, not because of added strength.

Limited evidenceSource: PMID:41037163
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:41439068, OMIM:310200
Notesplain_language confirmed from PMID:41439068 via curation 2026-06-18 [claude (tier3 curation)]. | regrounded primary OMIM:310200 -> PMID:41037163 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26

Elevated circulating creatine kinase activity

A markedly raised blood level of creatine kinase (CK), an enzyme released from damaged muscle, is an early clue and is often very high in this condition.

Limited evidenceSource: PMID:41037163
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:41439068, OMIM:310200
Notesplain_language confirmed from PMID:41439068 via curation 2026-06-12. | regrounded primary OMIM:310200 -> PMID:41037163 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26

Childhood onset

Duchenne is a childhood-onset muscular dystrophy. It is usually recognized in boys in early childhood.

Limited evidenceSource: PMID:16322188
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:41439068, OMIM:310200
Notesplain_language confirmed from PMID:41439068 via curation 2026-06-18 [claude (tier3 curation)]. | regrounded primary OMIM:310200 -> PMID:16322188 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26

Loss of ambulation

Walking ability is gradually lost, on average in the early teens, after which a wheelchair is needed.

Limited evidenceSource: PMID:16322188
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:41911965, OMIM:310200
Notesplain_language confirmed from PMID:41911965 via curation 2026-06-12. | regrounded primary OMIM:310200 -> PMID:16322188 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26

Obstructive sleep apnea

Younger people with duchenne muscular dystrophy can have pauses in breathing during sleep caused by a blocked airway (obstructive apneas). This risk is linked to weight gain that follows reduced physical activity and long-term corticosteroid treatment.

Limited evidenceSource: PMID:28397169
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesOMIM:310200
Notesplain_language confirmed from PMID:28397169 via curation 2026-06-24 [claude-draft]. | regrounded primary OMIM:310200 -> PMID:28397169 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26

Mild intellectual disability

Because dystrophin is also active in the brain, some boys with Duchenne have learning or cognitive difficulties, which can be mild and vary widely between individuals.

Limited evidenceSource: PMID:34727324
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:41869909, OMIM:310200
Notesplain_language confirmed from PMID:41869909 via curation 2026-06-18 [claude (tier3 curation)]. | regrounded primary OMIM:310200 -> PMID:34727324 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26

Delayed gross motor development

Reaching motor milestones late, such as sitting, standing, or walking, is a common early sign of Duchenne.

Limited evidenceSource: PMID:41037163
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:41439068, OMIM:310200
Notesplain_language confirmed from PMID:41439068 via curation 2026-06-18 [claude (tier3 curation)]. | regrounded primary OMIM:310200 -> PMID:41037163 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26

Dilated cardiomyopathy

The heart muscle is also affected over time, leading to a dilated cardiomyopathy that needs regular monitoring.

Limited evidenceSource: PMID:41391906
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:41037163, OMIM:310200
Notesplain_language confirmed from PMID:41037163 via curation 2026-06-12. | regrounded primary OMIM:310200 -> PMID:41391906 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26

Congestive heart failure

If the heart muscle weakens enough, it can lead to heart failure, where the heart cannot pump blood as effectively as the body needs.

Limited evidenceSource: PMID:41391906
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:41923738, OMIM:310200
Notesplain_language confirmed from PMID:41923738 via curation 2026-06-18 [claude (tier3 curation)]. | regrounded primary OMIM:310200 -> PMID:41391906 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26

Cardiomyopathy

Dystrophin is also needed by the heart muscle. Over time many people with Duchenne develop a weakened, enlarged heart (dilated cardiomyopathy), so heart monitoring is part of routine care.

Limited evidenceSource: PMID:27815032
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:41923738, OMIM:310200
Notesplain_language confirmed from PMID:41923738 via curation 2026-06-18 [claude (tier3 curation)]. | regrounded primary OMIM:310200 -> PMID:27815032 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26

Arrhythmia

In duchenne muscular dystrophy the heart can develop abnormal rhythms, both in the upper chambers (atrial) and lower chambers (ventricular). These arrhythmias tend to appear later in the course of the condition.

Limited evidenceSource: PMID:41391906
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesOMIM:310200
Notesplain_language confirmed from PMID:41391906 via curation 2026-06-24 [claude-draft]. | regrounded primary OMIM:310200 -> PMID:41391906 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26

X-linked recessive inheritance

Duchenne muscular dystrophy is inherited in an X-linked recessive pattern, which is why it predominantly affects boys, with the gene change carried on the X chromosome.

Limited evidenceSource: PMID:41037163
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesOMIM:310200
Notesplain_language confirmed from PMID:41037163 via curation 2026-06-12. | regrounded primary OMIM:310200 -> PMID:41037163 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26

Hypoventilation

In duchenne muscular dystrophy, breathing during sleep can become too shallow or slow, so the body takes in less oxygen and clears less carbon dioxide. This under-breathing is called hypoventilation.

Limited evidenceSource: PMID:28397169
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesOMIM:310200
Notesplain_language confirmed from PMID:28397169 via curation 2026-06-24 [claude-draft]. | regrounded primary OMIM:310200 -> PMID:28397169 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26

Respiratory failure

As the muscles used for breathing weaken, breathing support becomes increasingly important, and respiratory failure is a serious later complication.

Limited evidenceSource: PMID:28397169
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:42236981, OMIM:310200
Notesplain_language confirmed from PMID:42236981 via curation 2026-06-18 [claude (tier3 curation)]. | regrounded primary OMIM:310200 -> PMID:28397169 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26

Muscle weakness

Progressive weakness of the muscles closest to the trunk (hips, thighs, shoulders) usually appears in early childhood and is the core feature.

Limited evidenceSource: PMID:16322188
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:41439068, OMIM:310200
Notesplain_language confirmed from PMID:41439068 via curation 2026-06-12. | regrounded primary OMIM:310200 -> PMID:16322188 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26

Respiratory insufficiency due to muscle weakness

As duchenne muscular dystrophy progresses, the muscles used for breathing, especially the diaphragm, weaken. This weakness can make breathing inadequate, so oxygen levels fall, particularly in older people with the condition.

Limited evidenceSource: PMID:28397169
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesOMIM:310200
Notesplain_language confirmed from PMID:28397169 via curation 2026-06-24 [claude-draft]. | regrounded primary OMIM:310200 -> PMID:28397169 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26

Difficulty climbing stairs

Weakness in the muscles closest to the hips and shoulders makes activities like climbing stairs and getting up from the floor difficult.

Limited evidenceSource: PMID:40822690
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:41869909, OMIM:310200
Notesplain_language confirmed from PMID:41869909 via curation 2026-06-18 [claude (tier3 curation)]. | regrounded primary OMIM:310200 -> PMID:40822690 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26

Hypotonia

Young children with Duchenne can have low muscle tone (hypotonia), meaning the muscles feel floppy and provide less support than expected for their age.

Limited evidenceSource: PMID:19743977
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:41439068, OMIM:310200
Notesplain_language confirmed from PMID:41439068 via curation 2026-06-18 [claude (tier3 curation)]. | regrounded primary OMIM:310200 -> PMID:19743977 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26

Gowers sign

A 'Gowers sign', using the hands to push up the legs when rising from the floor, is a classic early sign of the hip and thigh weakness.

Limited evidenceSource: PMID:37970286
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:41439068, OMIM:310200
Notesplain_language confirmed from PMID:41439068 via curation 2026-06-12. | regrounded primary OMIM:310200 -> PMID:37970286 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26

Scoliosis

As trunk muscles weaken, the spine can curve sideways (scoliosis), particularly after a child stops walking.

Limited evidenceSource: PMID:31794463
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:41869909, OMIM:310200
Notesplain_language confirmed from PMID:41869909 via curation 2026-06-18 [claude (tier3 curation)]. | regrounded primary OMIM:310200 -> PMID:31794463 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26

How it is diagnosed

Duchenne muscular dystrophy

Diagnosed using: Serum creatine kinase (CK).

Limited evidenceSource: PMID:34626608
The source text this rests on
“…progressive proximal muscle weakness, elevated serum creatine kinase (CK), and delayed motor…”
An excerpt quoted verbatim from the source named above, shown as recorded. The full sentence is in the linked source.
Evidence ratingweak
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:41439068
Notesconfirmed from PMID:41439068 via curation 2026-06-18 | regrounded primary PMID:41439068 -> PMID:34626608 on 2026-06-19 [carrie]
Last reviewed2026-06-19

Duchenne muscular dystrophy

Diagnosed using: Genetic testing for DMD.

Limited evidenceSource: PMID:41869909
The source text this rests on
“Genetic testing using targeted panels or comprehensive genome sequencing is the current standard for diagnosing Duchenne muscular…”
An excerpt quoted verbatim from the source named above, shown as recorded. The full sentence is in the linked source.
Evidence ratingweak
Confidence (0-1)0.7
Replicationunreplicated
Notesconfirmed from PMID:41869909 via curation 2026-06-18
Last reviewed2026-06-18

Duchenne muscular dystrophy

Diagnosed using: Echocardiography.

Limited evidenceSource: PMID:41391906
The source text this rests on
“…electrocardiography (ECG) and echocardiography at diagnosis and annually…”
An excerpt quoted verbatim from the source named above, shown as recorded. The full sentence is in the linked source.
Evidence ratingweak
Confidence (0-1)0.7
Replicationunreplicated
Notesconfirmed from PMID:41391906 via curation 2026-06-24
Last reviewed2026-06-24

Treatment and management

What the research describes, not a recommendation. Treatment decisions belong with your clinician.

This covers treatments that appear in the published research mapped here. Investigational and experimental therapies are not included, so their absence is a boundary of this map, not a sign they do not exist.

Glucocorticoids

Glucocorticoids (corticosteroids such as prednisone or deflazacort) are the mainstay of treatment and can slow the loss of muscle strength, though they carry significant side effects.

Used to help with: Duchenne muscular dystrophy.

Limited evidenceSource: PMID:41894886
The source text this rests on
“Long-term glucocorticoid therapy is the mainstay of treatment for individuals with Duchenne muscular dystrophy (DMD) but confers significant side effects.”
An excerpt quoted verbatim from the source named above, shown as recorded. The full sentence is in the linked source.
Evidence ratingweak
Confidence (0-1)0.7
Replicationunreplicated
Notesconfirmed from PMID:41894886 via curation 2026-06-12
Last reviewed2026-06-12

Exon-skipping therapy

Exon-skipping medicines help some people with Duchenne make a partially working dystrophin protein. They only help those whose specific mutation matches the targeted exon (currently exons such as 51, 53, and 45), so eligibility depends on a person's exact DMD mutation.

Used to help with: Duchenne muscular dystrophy.

Limited evidenceSource: PMID:41898615
The source text this rests on
“…phosphorodiamidate morpholino oligomer (PMO) drugs targeting exons 51, 53, and 45 provide mutation-class-specific…”
An excerpt quoted verbatim from the source named above, shown as recorded. The full sentence is in the linked source.
Evidence ratingweak
Confidence (0-1)0.7
Replicationunreplicated
Notesconfirmed from PMID:41898615 via curation 2026-06-18
Last reviewed2026-06-18

Assisted ventilation

Assisted ventilation is breathing support used in duchenne muscular dystrophy as breathing muscles weaken. It usually starts at night, and daytime support is added as respiratory failure progresses.

Used to help with: Respiratory failure.

Limited evidenceSource: PMID:30275250
The source text this rests on
“…assisted ventilation (initially nocturnally, with the subsequent addition of daytime ventilation for progressive respiratory…”
An excerpt quoted verbatim from the source named above, shown as recorded. The full sentence is in the linked source.
Evidence ratingweak
Confidence (0-1)0.7
Replicationunreplicated
Notesconfirmed from PMID:30275250 via curation 2026-06-24
Last reviewed2026-06-24

How to read the evidence labels

Widely acceptedSpecialists broadly agree on this.
Strong evidenceBacked by solid, repeated research.
Moderate evidenceReasonable evidence, still being confirmed.
Limited evidenceSome evidence, but not yet convincing.
Early evidenceAn early finding that needs more study.
Experts disagreeResearchers actively disagree about this.
No longer supportedLater, stronger evidence or guidance overturned this.

Where this comes from

This guide is built from 18 published source(s). Every claim above links back to one of them. Click any source ID to read the original on PubMed.

OMIM:310200 · Orphanet/HPO annotations for Duchenne muscular dystrophy
PMID:16322188 · Cardiovascular health supervision for individuals affected by Duchenne or Becker muscular dystrophy.
PMID:19743977 · A review of nutrition in Duchenne muscular dystrophy.
PMID:27815032 · Pharmacological therapy for the prevention and management of cardiomyopathy in Duchenne muscular dystrophy: A systematic review.
PMID:28397169 · Sleep Disordered Breathing in Duchenne Muscular Dystrophy.
PMID:30275250 · Respiratory Management of the Patient With Duchenne Muscular Dystrophy.
PMID:30275252 · Orthopedic and Surgical Management of the Patient With Duchenne Muscular Dystrophy.
PMID:31794463 · The Dystrophinopathies.
PMID:34626608 · Creatine kinase test diagnostic accuracy in neonatal screening for Duchenne Muscular Dystrophy: A systematic review.
PMID:34727324 · Clinical and Molecular Spectrum of Muscular Dystrophies (MDs) with Intellectual Disability (ID): a Comprehensive Overview.
PMID:37970286 · Development and Validation of an Outpatient Clinical Predictive Score for the Diagnosis of Duchenne Muscular Dystrophy/Becker Muscular Dystrophy in Children Aged 2-18 Years.
PMID:40822690 · Patient demographics, clinical characteristics and genetic mutations of DMD and BMD patients in Qatar Epidemiological and genetic profile of Duchenne muscular dystrophy and Becker muscular dystrophy patients in Qatar: a retrospective cohort study.
PMID:41037163 · Dystrophinopathies.
PMID:41391906 · Cardiac care in Duchenne muscular dystrophy.
PMID:41439068 · title on PubMed
PMID:41869909 · Optical Genome Mapping and Long-Read Sequencing Identifies a Novel Dystrophin Gene Inversion in a Patient With Duchenne
PMID:41894886 · From case to caution: hyponatremia in a patient with Duchenne muscular dystrophy on vamorolone and lessons for clinician
PMID:41898615 · RNA Therapeutics for Duchenne Muscular Dystrophy: Exon Skipping, RNA Editing, and Translational Insights from Genome-Edi

Take it further

Printed, source-linked documents built from this condition's graph — ready to bring to an appointment or attach to a coverage request. Every claim carries its published source, the same as this guide.